Is there anything different about Novavax?
The Novavax jab is a protein-based vaccine, and it uses more established vaccine technology than others.
Professor Sir Munir Pirmohamed, Chair of the independent Commission on Human Medicines, said: “We are pleased to say that we have advised that the benefit-risk balance of Nuvaxovid is positive.
“Nuvaxovid is distinct from other COVID-19 vaccines currently in use in the UK as it uses recombinant protein-based technology which has been used for many years in the development of vaccines to prevent other illnesses, for example, Hepatitis B.